RxDoctor Payments Data

Michael Zimmerman

Foot & Ankle Surgery · Oneill, NENPI 1699118224

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Stryker at 41.3% of the total. Reporting peaked in 2022 at $8,228 and has fallen 78.3% since, to $1,787 in 2025.

$26,325in general payments, 2019–2025

Across 348 payments — averaging $75.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$11K
  • Arthrex$9K
  • Conetic Solutions, Inc.$4K
  • Integra Lifesciences Corporation$876
  • Smith+Nephew$633
  • Musculoskeletal Transplant Foundation Inc.$375
  • plus $806 from 16 others

What the payments were for

  • Travel & lodging$6,81326%
  • Food & beverage$12,57548%
  • Education$6,18423%
  • Other$7533%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,325 in reported general payments places this provider in the 80th percentile of 43 foot & ankle surgery providers in Nebraska.

See all foot & ankle surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$64,022
Medicare patients
234
Services billed
1,004

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox15$583
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip11$228
Oxycodone Hcl38$205
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$199
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$129
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$125
Ibuprofen13$111
Tramadol Hcl14$51

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Oneill

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →